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ABSTRACT  This atlas illustrates the microscopic features of tumors produced from human pluripotent stem 
cells (hPSCs) xenografted into immunosuppressed mice, according to the generally accepted protocols for per-
forming this teratoma assay of stem cell pluripotency. Microphotographs depict various hematoxylin and eosin 
(H&E) stained tissues derived from all three embryonic germ layers (ectoderm, mesoderm and endoderm). The 
appearance of persistent hPSC in teratomas is also described with special emphasis on the morphogenesis of 
embryoid bodies and yolk sac components surrounding them. The use of immunohistochemistry for analyzing 
hPSC-derived teratomas is also illustrated. 
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Human embryonic stem cells derived from pre-implantation embryos are pluripotent cells capable of differentiating 
into various somatic cells and or tissues (Thomson et al., 1998). Developmentally equivalent cells, termed induced 
pluripotent stem cells (IPSC), can be produced by reprogramming somatic cells (Takahashi and Yamanaka, 2006; 
Takahashi et al., 2007; Yu et al., 2007). In this Atlas we refer to these cell types, irrespective of their origin or derivation, 
as human pluripotent stem cells (hPSC).
From the historical point of view it is worth mentioning that isolation of hPSC was preceded by studies on human 
embryonal carcinoma cells (ECC) derived from human germ cell tumors (Andrews et al., 1980,1984, Pera et al., 1989). 
Since the pluripotency of single mouse embryonal carcinoma cell was demonstrated in vivo, by injecting individual cells 
into adult mice (Kleinsmith and Pierce, 1964), it was assumed the same approach could be used to test the pluripotency 
of mouse and human embryonic stem cells, human embryonal carcinoma cells, and all other hPSC (Andrews et al., 
2005; Solter, 2006; Adewumi et al., 2007). For testing mouse cell pluripotency, syngeneic mice could be used as graft 
recipients (Solter, 2006). However human ECC or hPSC had to be injected into immunodeficient mice. Histopathologic 
examination of the resulting tumors was used to determine whether they could differentiate into mature tissues and thus 
express their complete developmental potential (Andrews et al., 2005). Comparison of hPSC and ECC showed that ECC 
are the malignant equivalents of hPSC, in a manner that mouse embryonal carcinoma cells are the malignant equiva-
lents of embryonic stem cells (Andrews et al., 2005; Solter 2006). Cells forming teratomas, i.e. xenografts composed 
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of derivatives of all three embryonic germ layers (ectoderm, mesoderm and endoderm) were deemed in this teratoma 
assay to be developmentally pluripotent (Adewumi, et al., 2007; Amps, et al., 2011). Even though there are many tests 
of pluripotency in vitro, some of which include molecular biology examination of hPSC, the murine xenograft teratoma 
assay remains a gold standard used to reliably demonstrate pluripotency of these cells grown in vitro (reviewed by 
Hentze et al.,2009).
The teratoma assay was developed primarily as a test of pluripotency of hPSC. However, as we have pointed out 
previously (Damjanov and Andrews, 2007), it could also be used as a screening test for detecting malignant transforma-
tion of the hESC, as well as for detecting various forms of complex morphogenesis or even organogenesis that would not 
occur in vitro. To illustrate the full potential of the mouse xenograft teratoma assay and to pinpoint some of its limitations 
and potential problems, we assembled a panoply of microphotographs prepared from the xenografts produced over the 
years by the members of the International Stem Cell Initiative (ISCI).
Historical definition of teratoma
Teratomas are tumors that have intrigued biomedical scientists for many years (Damjanov and Wewer-Albrechtsen, 
2013). The actual term teratoma was coined by Rudolf Virchow (1863) from two Greek words: teras meaning monster 
and onkoma meaning swelling or tumor. Ewing (1911 and 1919) defined teratomas as “complex tumors composed of 
tissues and organs of one, two or three germinal layers, as monodermal, bidermal or tridermal types”. Willis (1951), 
writing in the first edition of the Armed Forces Institute of Pathology (AFIP) Atlases, deleted from his definition the refer-
ence to germ layers and defined teratoma as a “true tumor or neoplasm composed of multiple tissues of kinds foreign to 
the part in which it arises”. Mostofi and Price (1973) defined testicular teratoma as a “complex tumor with recognizable 
elements of more than one germ layer in various stages of maturation, often arranged in such a manner as to suggest 
abortive organ formation”. These authors also mention a number of historic synonyms and related terms, as follows: 
dysembryoma, embryoma, teratoblastoma, teratoid tumor, malignant teratomas, intermediate A and B. 
Scully (1979) writing about ovarian teratomas was more precise, stating that “most teratomas contain several types 
of tissue that recapitulate the development of two or three embryonic layers (endoderm; mesoderm; ectoderm). The 
neoplastic components may be entirely mature, entirely immature or both mature and immature. In occasional cases, 
differentiation is monodermal, or almost so, as evidenced by the exclusive or predominant formation of a single highly 
specialized type of tissue”. British pathologists nevertheless remained unconvinced by these American efforts and 
retained their own classification, in which they used the term teratoma with different prefixes for all testicular germ cell 
tumors except for seminoma, (Pugh, 1976) (Table 1).
AFIP (Dixon and More,1951) British Testicular  Tumour Panel (Pugh,1976)  World Health Organization (Moch et  al, 2016)* 
Seminoma Seminoma Seminoma 
Embryonal carcinoma Malignant teratoma, undifferentiated Embryonal carcinoma 
Teratoma with embryonal carcinoma (teratocarcinoma) Malignant teratoma, intermediate Nonseminomatous germ cell tumor(NSGCT) 
  -Mixed germ cell tumor 
Teratoma, adult Teratoma, differentiated Teratoma, postpubertal type 
Choriocarcinoma Malignant teratoma, trophoblastic Choriocarcinoma 
TABLE 1
COMPARISON OF THREE MAJOR CLASSIFICATIONS OF HUMAN TESTICULAR TUMORS
 AFIP-Armed Forces Institute of Pathology, Washington, DC
*Only the part of the WHO classification pertaining to germ cell tumors derived from germ cell neoplasia in situ and corresponding to the tumors in the AFIP and British Testicular 
Tumour Panel was included in this table.
Pragmatic definition of teratoma
For researchers dealing with hPSC, teratoma (without any additional qualifier) is best defined as a benign tumor 
composed of mature somatic tissues arranged in a disorderly manner. All standard textbooks of human pathology de-
fine teratomas in oncologic and developmental biology terms. From the oncologic point of view there is no doubt that 
teratomas are true neoplasms; the haphazard arrangement of tissues, ”recapitulating” or “resembling” various somatic 
derivatives, points to an abnormal development of tissues inside the tumor. Experimental teratomas produced in rodents 
re-emphasize this dual developmental/oncologic nature of teratomas (Solter, 2006). Teratomas produced in mice from 
xenografted hPSC can be identified by the naked eye as tumors that grow on their own, and thus escape any growth 
inhibitory mechanisms in the host. They are thus “real tumors”, readily recognized by the examiner as being different 
from other tissues or organs of the host. 
Comments
Issue of three germ layer derivatives
Most human teratomas contain derivatives of all three embryonic germinal layers, although in practical terms this is 
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not a sine qua non for diagnosing a tumor as teratoma. Those tumors that have derivatives of all three germ layers are 
also known as “tridermomas”. Some tumors contain only derivatives of two germ layers and are thus also known as 
“bidermomas”. Tumors predominantly or exclusively composed of cells or a tissue derived from a single germ layer (e.g. 
thyroid goiter of the ovary) are called “monodermal or monophyletic teratomas”. Xenografts produced in mice injected 
with hPSC typically contain tissues derived from all three germ layers, although in some instances a certain tissue may 
predominate forming over 90% of the entire graft. This is most prominently seen in teratomas composed of neural tissue. 
“Monodermal” or “highly specialized” teratomas composed of a single cell type, can be produced in mouse xenografts 
from committed stem cells generated in vitro from undifferentiated hPSC, such as islet cell precursors (Schultz,2015).
Location
Although Willis (1951) defined teratomas in terms of location (“multiple tissues foreign to the part in which it arises”), 
experimental data show that teratomas can be experimentally produced in any site (Solter, 2006). The same holds true 
for the teratomas produced by xenografting of hPSC in immunodeficient mice (Adewumi,et al., 2007). Teratomas can 
be produced from hPSC xenografted to any anatomic site in immunodeficient mice (reviewed by Hentze et al.,2009).
Benign versus malignant
These terms refer to the clinical presentation of various tumors and the final outcome of the neoplastic disease. Ovar-
ian teratomas composed of mature somatic tissues are almost all benign and do not endanger the life of the host. On 
the other hand, in the testis, even the pathologically diagnosed “benign” teratomas may clinically behave as malignant, 
metastasize and kill the host. Hence, many authorities suggest that the extra-ovarian teratomas should be clinically 
observed for possible malignancy that cannot be recognized histologically. Experimentally produced and spontaneous 
teratomas of mice are benign and can be readily distinguished from malignant teratocarcinomas (Solter, 2006). The 
biological nature of teratomas produced from hPSC xenografted into immunodeficient mice cannot be determined with 
certainty. In part this relates to the limited time of observation of grafted animals, and in part it is related to the nature of 
the experiments that have been performed so far, not allowing us to address properly the nature of possible malignancy 
in the xenografts.
Immature teratomas
Teratomas composed of mature and immature tissues are classified as immature teratomas. The significance of 
this distinction is best seen in the ovary: 99% of teratomas of the ovary are composed of mature tissue, and 1% are 
considered to be immature (Scully, 1979). In contrast to teratomas composed of mature somatic tissues, which are by 
definition clinically benign, immature ovarian teratomas are malignant tumors, which can metastasize and endanger the 
life of the host. The immaturity of other somatic tissues is clinically of no significance.
Comment
Presence of immature tissues
The issue of immature tissue in teratomas produced from xenografted hPSC is a conundrum that cannot be solved 
readily. Neural rosettes and neural tube-like tissue are very common in xenografts and sometimes they represent the 
predominant tissue in such tumors. On the basis of the experience with immature ovarian teratomas which also contain 
neural tube like tissues and neural rosettes, one could assume that such graft are potentially malignant and could dis-
seminate. A simple experiment in which one would remove such a graft, dice it and inject these small pieces into the 
abdominal cavity of another mouse could answer, at least in part, the question of whether such tumors have the capacity 
to spread through the body or body cavities of immunosuppressed mice. 
Malignant transformation of benign teratomas
Benign ovarian teratomas which are left in situ for many years without surgical intervention may undergo malignant 
transformation. (Most often such malignant tumors are classified as squamous cell carcinomas (Hackethal et al.,2008) 
but other tissues may undergo malignant transformation as well. There are reports of adenocarcinomas, various sarcoma 
and gliomas originating in benign teratomas.
Comment
Malignant transformation
Transformation of benign teratomas into somatic malignant tumors, such as carcinoma, sarcoma or lymphoma, has 
not been observed in teratomas produced from xenografted hPSC. Such transformation occurs in human ovarian tera-
tomas over a prolonged period of time, and thus it seems unlikely for it to occur in mice bearing hPSC-derived teratomas 
during the short they are typically observed.
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Teratocarcinoma-malignant teratoma
Teratocarcinoma is a term used predominantly by scientists working on mouse germ cell tumors and embryo derived 
teratoid tumors (Damjanov and Andrews, 2012). The term was initially introduced by Friedman and More (1946) to 
denote malignant germ cell tumors composed of embryonal carcinoma cells and teratoma components. The term tera-
tocarcinoma was, however, abandoned by clinical pathologists to be replaced by terms such a mixed germ cell tumor 
or non-seminoma, or nonseminomatous germ cell tumor (NSGCT).
According to the teaching of Friedman and Moore (1946), which was included in the AFIP Atlas on testicular tumors 
(Dixon and Moore, 1952), undifferentiated ECC are the malignant stem cells of teratocarcinomas. ECCs are capable of 
rapid growth and metastasis, but at the same time they can differentiate into somatic tissues and lose their malignancy. 
This concept of reversible malignancy was proven operational in clinical cases with metastases; under the influence of 
chemotherapy such metastases lost the ECC component and transformed into well differentiated teratomas (Ulbright,1999). 
In vitro studies with human embryonal carcinoma cells confirmed, in principle, the notion that ECC can differentiate 
and lose their malignancy (Andrews et al., 2002). Comparison of human ECC and hPSC grown in vitro revealed many 
similarities, including their immunoprofile and developmental pluripotency (Andrews et al., 2002).
Comment
The significance of embryonal carcinoma cells
The presence of undifferentiated ECC in a clinically diagnosed teratoma automatically changes its diagnosis from 
benign to malignant. The same principle is used to diagnose malignant teratoid tumors in mice, and all tumors containing 
identifiable ECC are labeled as teratocarcinomas (Lin, et al., 2015). The obvious question, applied mutatis mutandis to 
hPSC grafted to immunosuppressed mice, is as follows: Are tumors that contain undifferentiated cells resembling ECC 
benign or malignant? The answer is: Nobody knows.
Malignancy of hPSC derived teratomas
Without proper experimental proof of malignancy of teratomas that contain undifferentiated hPSC 6-8 weeks after 
xenografting, all discussions are moot. Nevertheless, the presence of such undifferentiated hPSC in 6-8 week old grafts 
is at least a topic that needs to be explored. In view of the potential (but not proven) malignancy residing in these undif-
ferentiated hPSC that resemble human ECC (“human ECC-like cells”), more experiments are indicated. For example, 
parts of the tumors obtained from xenografted hPSC could be retransplanted into other mice to see if the tumor stem 
cells will form new tumors faster and contain more undifferentiated or human ECC-like cells, invade host tissue or even 
metastasize, thus proving that the tumors are malignant indeed. 
Teratocarcinoma
This term has been rejected by clinical pathologists, although it is commonly used by laboratory scientists working 
with mice (Solter, 2006). Should one use this term for malignant teratomas produced from xenografted hPSC? No 
consensus has been reached so far, although it seems logical to use a specific term for malignant tumors proven to be 
malignant by established biomedical criteria (Damjanov and Andrews,2007).
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SECTIONS
Abbreviations used in this Atlas: B, bone; Bv, blood vessel; C, cartilage; Cp, choroid plexus; End, endodermal; EB, embryoid body; ECC, embryonal 
carcinoma cell; F, fat; hPSC, human pluripotent cell; iPSC,  induced pluripotent stem cell; M, muscle; Mes, mesenchymal stroma; Neu, neural cell; 
Np, neural plate; Nt, neural tube; O, osteoid; Pig, pigmented; Sm, smooth muscle; Sc, stratified cylindrical epithelium; Sq, squamous epithelium; 
V, vacuolated.
Note: Except for Fig. 33, all sections in this Atlas are conventionally stained with hematoxylin and eosin (H&E). 
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Synoptic view of xenografts
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Fig. 1. Representative whole mount sections of nine xenografts. (A-J) The samples (E,F,G) were bisected in half and 
thus contain much more tissue for examination. Magnification: 4x. Specimens (I,J,K) appeared larger in the mouse upon 
harvesting because the cystic spaces within the xenografts were expanded by the fluid, which has escaped upon sectioning. 
Magnification: (H) 120x; (I) 180x; (J) 180x.
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Fig. 2. Xenograft presented in Fig. 1A photographed at higher magnifications. (A) 40x; (B) 80x. Abbreviations: Cp, choroid plexus; End, 
endodermal; Neu, neural.
Human Experimental Teratoma Atlas    349 
BA
350    I. Damjanov and P. W. Andrews
Fig. 3. Teratomas, panoramic view. (A) Higher magnification view of Fig. 1D. (B) A typical teratoma containing ectodermally derived neural 
tissue (Neu), mesodermally derived cartilage (C), muscle (M) and endodermal tubes (End). Magnification: (A) 80x; (B) 160x.
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Fig. 4. Teratoma, panoramic view. (A) The xenograft is composed predominantly of immature neural tissue (Neu), some choroid plexus (Cp), 
a few endodermal tubes (End) surrounded by mesenchymal stroma (Mes). (B) Higher magnification view of the neural component in the right 
sided part the teratoma. Magnification: (A) 80x; (B) 120x.
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Fig. 5. Teratoma, panoramic view. (A) This xenograft is composed of approximately equal parts of endodermal (End),mesodermal derivative 
(Mes)  including bone (B) and cartilage (C), and ectodermal derivative, such as neural tissue(Neu). (B) Another teratoma showing equal repre-
sentation of derivatives of all 3 germ layers. Magnification: (A,B) 120x.
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Fig. 6. Teratomas containing derivatives of all three germ layers. (A) Teratoma contains endodermal tubes (End), and ectodermal tissues, 
including squamous epithelium (Sq) and neural tissue (Neu). Mesoderm derived stroma is seen between these elements. (B) In this teratoma, 
ectodermal derivatives are represented by neural tissue (Neu), endodermal derivatives by the liver, and mesodermal derivatives by the stroma. 
(C) In this teratoma, ectodermal derivatives are represented by dispersed immature neural tissue and neural rosettes (Neu), endodermal de-
rivatives by a endodermal tube (End) with subnuclear vacuoles, and the mesodermal derivatives by cartilage (C) and loose stroma. (D) Higher 
magnification of neural tissue focally forming rosettes (Neu) and vacuolated endodermal tube(End). The mesodermal stroma in the upper part 
is loose and in the lower part of the figure dense. Magnification: (A) 180x; (B) 200x; (C) 180x; (D) 280x.
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Fig. 7.  Teratomas containing yolk sac (YS) components intermixed with hPSC. (A) In this teratoma YS and hPSC form just a very small 
component (framed). Immature neural tissue is the most prominent component, and it is focally admixed with mesenchymal stroma. (B) Yolk 
sac components admixed with hPSC account for the entire photographed part of this teratoma. Magnification: (A,B) 120x.
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Fig. 8. Teratomas composed of undifferentiated cells that cannot be further classified. (A) This tumor contains numerous cystic and tube-
like structures formed of undifferentiated cells which have condensed nuclei and scant cytoplasm. It is possible that these cells represent 
precursors of neural cells or endodermal structures, such as intestines and bronchi. However without additional studies, these cells cannot be 
properly identified. Magnification: (A) 120x; (B) 220x.
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Fig. 9. Teratomas composed of cells which cannot be further classified. (A) Teratoma composed of ducts and tubules lined by undifferenti-
ated cells with condensed nuclei and scant cytoplasm. (B) Teratoma composed of the same cells as shown in (A). However this one has more 
stroma between the tubes formed of unidentified cells. (C) Teratoma made up of duct like structures surrounded by hyaline stroma. (D) Irregular 
spaces lined by flattened epithelium which cannot be further characterized. Magnification: (A,B) 80x; (C,D) 180x.
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Fig. 10. Neural tissue. (A) Neural rosettes forming a distinct nodule delimited from the empty space by layer of cells lying on a membrane. 
These rosettes seem to converge toward a virtual center left of the midfield (asterisk). (B) Neural tubes resemble neural rosettes, but in con-
tradistinction to them, they have a central slit lumen. (C) Confluent neural tubes and rosettes. (D) Neural tubes surrounded by sheets of small 
neural precursor cells arranged without any discernible structure. Magnification: (A,B) 160x; (C,D) 120x.
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Fig. 11. Neuropil formed around neural tubes. (A) Neural tubes surrounded with eosinophilic neuropil reflecting the fact that these neural 
and glial cells have more cytoplasm that their immature precursor cells which appear blue. (B) Neuropil in the left upper corner appears more 
eosinophilic than the neuropil next to it in the lower left side. The cells forming the neuropil have in either case more cytoplasm then the imma-
ture neural cells to the left of the rosettes, and along the lower edge of the figure. (C) Neural rosettes surrounded with rather pale neuropil. (D) 
Variegated cellularity and eosinophilia, probably reflecting the level of maturation of neuropil. Two bluish cell nests in the midline are composed 
of immature neural cell precursors. Magnification: (A) 220x; (B) 180x.
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Fig. 12. Neural tube and derivatives. (A) Dilated neural tubes filled with choroid plexus forming confluent papillary structures in the right up-
per hand corner. (B) Choroid plexus composed of clear cells. At the margins of the nest of choroid plexus there are pigmented cells (Pig). (C) 
Choroid plexus composed of vacuolated cuboidal cells forming papillae. (D) Choroid plexus papillae projecting into a cystic space. Magnifica-
tion: (A) 120x; (B) 160x; (C) 180x; (D) 220x.
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Fig. 13. Neural tissue and eye structures. (A) Pigmented cells forming a layer that is partially enclosing a nest of lentoid cells. These cells 
with small round nuclei and abundant eosinophilic cytoplasm are precursors of the lens in the eye. (B) Lentoid cells forming a protrusion in the 
attenuated epithelium of the neural tube, reminiscent of eye formation. Magnification: (A) 160x; (B) 280x. 
Human Experimental Teratoma Atlas    373 
BA
374    I. Damjanov and P. W. Andrews
Fig. 14. Pigmented cells. (A) Cells containing brown pigment are in continuity with neural rosettes or form rosette-like structures, best seen 
at the lower margin of the figure. (B) Overgrowth of pigmented cells which occupy a large part this tumor. Magnification: (A) 160x; (B) 100x.
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Fig. 15. Squamous epithelium. (A) Nest of immature squamous cells, which contain glycogen in their cytoplasm, thus appearing clear. The nest 
is rimmed by a basal layer of smaller darker cells lying on a basement membrane delimiting the squamous cells from the surrounding stroma. 
(B) Nascent squamous nests attached to a tube, which is surrounded by dense stroma. (C) Squamous cell nest originating from nondescript 
columns of epithelial cells on the lower side of the figure. The squamous cells show focal keratinization (red). (D) Squamous nest next to a 
nidus of cartilage. This squamous epithelial nest lacks the distinct basal layer. Magnification: (A,B,C,D) 180x.
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Fig. 16. Endodermal tubes. (A) Duct-like structures lined by polarized columnar cells which have basally located nuclei and well developed 
eosinophilic cytoplasm. The apical pole of these cells delimits a central lumen. Many cells are vacuolated. These cells cannot be further char-
acterized, but most likely they represent precursors of the tubular part of the gastrointestinal tract or bronchial tree. The stroma surrounding 
these tubules appears “very blue”, indicating that the stromal cells represent fetal-like mesenchyme, as seen during early stages of normal 
organogenesis. Compare this dense stroma with the loosely structured stroma in the left upper quadrant. (B) An endodermal tubule, composed 
of cells that show subnuclear vacuolization, is surround by concentrically layered stromal cells. (C) Tubules lined by mucus-secreting cells. (D) 
Dilated tubular structures lined by several types of epithelium, such as stratified cylindrical epithelium (Sc), cuboidal vacuolated epithelium(V), 
and focal squamous epithelium (Sq). Magnification: (A,C,D) 160x; (B) 280x.
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Fig. 17. Endodermal tube with condensation of stroma. (A) Several endodermal tubes, two of which show condensation of the stroma 
surrounding them. (B) Endodermal tube with condensation of stroma in a promontory pushing into the tube and invaginating it (arrow). (C) 
Intestine formation with concentric layering of loose stroma composed of spindle cells which also start forming smooth muscle cells. (D) 
Intestine formation with a distinct eosinophilic smooth muscle layer encircling the submucosa. Magnifications (A,B) 120x; (C) 160x; (D) 80x.
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Fig. 18. Endodermal tube with liver cells. (A) Endodermal tube with a nidus of liver tissue attached to it (arrow). (B) Endodermal tube and 
liver tissue. (C) Endodermal cells and liver cells admixed with blood cell precursors, which appear as small dark round cells in the central lumen. 
(D) Cords and nests of liver cells. Magnification: (A,B,C) 280x.
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Fig. 19. Cartilage and bone. (A) An aggregate of cartilage cells (C) and a small nidus of bone (B) in loosely structured stroma showing some 
condensation in the left upper part of the figure. (B) Bone rimming a nidus of immature cartilage. (C) Bone formation with peripheral calcification 
within a nidus of cartilage (enchondral ossification). (D) Bone formation comprising osteoid and calcified bone trabeculae within loose connective 
tissue (membranous ossification). Osteoids appear pink and the calcified bone is blue. Magnification: (A) 160x; (B,C,D) 220x.
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Fig. 20. Osteoid and cartilage formation. (A) An eosinophilic osteoid (O) is surrounded by fibroblast-like cells. (B) An osteoid surrounded by a 
layer of plump osteoblasts, most prominently on the left side. (C) Close juxtaposition of cartilage to neural, pigmented and lentoid epithelium. 
(D) Close juxtaposition of cartilage to an endodermal tube. Magnification: (A,B) 220x; (C,D) 160x.
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Fig. 21. Mesenchymal cells showing structural changes. (A) Loosely textured connective tissue with central condensation, probably cor-
responding to the formation of cartilage. An endodermal tube is seen towards the top of the figure. (B) Higher magnification of a condensed 
area corresponding to early chondrogenesis. (C) Three nests of mesenchymal cells: one in the upper left part of the figure is composed of 
loosely structured cells, the one to the upper right contains a central nidus of cartilage, whereas the one in the lower mid-portion contains a 
central area of dark bluish cells which could not be further characterized. (D) An endodermal tube (End) is seen adjacent to a mesenchymal 
loose connective tissue area (to the left). Vascular or lymphatic spaces are seen along the left margin and are adjacent to an area containing 
smooth muscle (Sm). Magnification: (A) 120x; (B) 280x; (C) 180x; (D) 160x.
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Fig. 22. Mesenchymal stroma. (A) Stroma composed of spindle cells appears loose on one side of the endodermal tubule (above it), and 
condensed below. (B) Loose stroma on the right side is composed of cells with round or oval nuclei and scant if any cytoplasm, reminiscent 
of fetal mesenchyme. It appears focally to impinge on the tubule (arrow). Dense stroma on the left side is separated from the epithelium by a 
basement membrane. Magnification: (A,B) 280x.
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Fig. 23. Mesenchymal epithelial transition. (A) In the center of a condensed mesenchyme, there are interconnected cells forming cords and 
small nests. (B) Higher magnification of the nascent epithelial cells. Magnification: (A) 160x; (B) 280x.
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Fig. 24. Angiogenesis. (A) Small inter-anastomosing blood vessels (Bv) filled with blood are seen next to an endodermal tube in the lower part 
of the figure. (B) Small blood vessels on the right upper side and larger blood vessels on the left and lower right side. (C) Dilated thin walled 
vessels (asterisks) surround an embryoid body with prominent apoptosis (arrow). (D) Large vessels (asterisks) and buds of small blood vessels 
in their walls.
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Fig. 25. Mesenchymal tissues. (A) Groups of fat cells (F) and smooth muscle cells (Sm) close to a field composed of neural tissue. (B) Fat 
tissue composed of mature fat cells and less mature (fetal) fat cells in the left lower portion of the figure. Neural tissue occupies the upper part 
of the field and forms a rim at the bottom. (C) Smooth muscle cell-rich stroma surrounding nests of squamous epithelium and neural tissue. 
(D) Hyaline intercellular matrix surrounding small groups of vacuolated cells that cannot be identified. The possibility that this hyaline rich tissue 
represents parietal yolk sac cannot be excluded. Magnification: (A,B,C) 160x; (D) 220x.
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Fig. 26. Embryoid bodies and yolk sac. (A) Embryoid body composed of human pluripotent stem cells (hPSC) is surrounded by loosely struc-
tured yolk sac, which in turn is surrounded by dense stroma. (B) Embryoid body surrounded by yolk sac that shows prominent angiogenesis, 
and contains small blood vessels filled with red blood cells. (C) Details of (B) photographed at higher magnification. (D) Tube composed of 
hPSCs, corresponding to a simple embryoid body, but lacking the typical yolk sac components around it. Yolk sac components can be seen in 
in the upper part of the figures. Magnification: (A) 80x; (B) 160x; (C) 220x; (D) 100x.
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Fig. 27. Human pluripotent stem cells (hPSCs). (A) Inter-anastomosing cords of hPSCs surrounded by fat cells which have clear cytoplasm. 
(B) hPSCs forming cords or compact nests. Note the typical loosely structured nuclear chromatin and overlapping nuclei. (C) hPSCs forming 
nests of cells that are not clearly demarcated from the adjacent tissue. (D) An embryoid body adjacent to loosely structured yolk sac on the 
right side. Magnification: (A) 160x; (B,C,D) 280x.
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Fig. 28. Human pluripotent stem cells (hPSCs). (A) hPSCs have typical nuclei with loosely structured chromatin and show focal apoptosis 
(upper part of the figure). Compare the nuclei of hPSC (asterisk) with those of the neural cells in the lower part of the figure. (B) hPSCs in this 
field cannot be definitively identified and are intermixed with other, possibly neural cell precursors. (C) hPSCs forming cords or plates (asterisk) 
surrounded by neural cells, which have more condensed nuclei. (D) Cords of hPSCs in continuity with neural cells occupying the upper part of 
the figure. Arrows indicate a areas of apoptosis. Neu, neural tissue. Magnification: (A,B,C,D) 280x.
Human Experimental Teratoma Atlas    409 
B
C D
A
410    I. Damjanov and P. W. Andrews
Fig. 29. Apoptosis of human pluripotent stem cells (hPSCs). (A) hPSCs forming cords and nests that are clearly separated from other cells. 
Occasional apoptotic cells with dark condensed nuclei are seen. (B) A nidus of hPSCs with prominent apoptosis. The nuclei of apoptotic cells 
appear dense, small and round. (C) hPSCs surrounding a cavity (asterisk) that most likely formed by apoptosis of centrally located cells. The 
lumen of the cavity contains single apoptotic cell nuclei. (D) Two layers composed of hPSCs showing prominent apoptosis. Magnification: 
(A,B,C,D) 280x.
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Fig. 30. Yolk sac. (A) Yolk sac is composed of strands and cords and loosely structured stroma. (B) Focally within the yolk sac, one may see 
darker cells forming cords, but without immunohistochemistry one cannot tell if these cells are hPSCs. (C) In addition to darker cells, this yolk 
sac contains foci of liver cells which stand out due to their pink cytoplasm (arrow). (D) Foci of hematopoiesis next to liver cells. Magnification: 
(A,B,C) 160x; (D) 240x.
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Fig. 31. Yolk sac with putative hPSCs. (A) Loosely structured yolk sac with cords of unidentified cells which may be hPSCs. (B) Another view 
of a yolk sac with possible hPSCs. The small cells with round nuclei most likely correspond to hematopoiesis. (C) Another area of yolk sac with 
a compact embryoid body in the upper midfield and a loosely structured one towards the lower edge of the figure. (D) A loosely structured yolk 
sac with a branching tubule, possibly lined by hPSCs. A nidus of liver cells is seen in the lower midfield. Magnification: (A,B,C) 280x; (D) 160x.
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Fig. 32. Hematopoiesis in the yolk sac. (A) Nucleated red blood cell and white blood cell precursors forming a nest of hematopoiesis in the 
loose stroma. (B) Hematopoietic precursor cells are seen in a vascular space (arrow). (C) Hematopoietic cells lined in a row are seen in a dilated 
vascular space (arrow). (D) Small groups of cells with dark round nuclei corresponding to hematopoietic islands in a loosely textured yolk sac 
area (arrow). Magnification: (A,B,C,D) 280x.
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Fig. 33. Immunohistochemistry. (A) Human pluripotent stem cells (hPSCs) show nuclear staining with the antibody to OCT4. (B) hPSCs react 
with the antibody TRA-1-60. (C) Yolk sac reacts with antibodies to alpha-fetoprotein. (D)Yolk sac cells react with the antibody to glypican-3. 
Magnification: (A,B,C,D) 160x.
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